Business Context and Reporting Period
Company: PerkinElmer, Inc. (Note: Metadata lists "REVVITY, INC." but the filing text identifies the registrant as PerkinElmer, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 2, 2000
Business Overview: A high-technology company operating in four segments: Life Sciences, Optoelectronics, Instruments, and Fluid Sciences. The company operates in over 100 countries and is a component of the S&P 500 Index.
Key Financial Metrics
| Metric | Q1 2000 | Q1 1999 |
|---|---|---|
| Sales (Revenue) | $402.3 million | $243.2 million |
| Operating Income | $35.9 million | $17.0 million |
| Net Income | $16.2 million | $14.1 million |
| Diluted EPS | $0.32 | $0.31 |
| Operating Cash Flow | $12.3 million | $10.2 million |
| Cash and Equivalents | $112.0 million | $106.3 million |
| Short-Term Debt | $340.2 million | $382.2 million |
| Long-Term Debt | $114.9 million | $114.9 million |
Margins: Operating margin for continuing operations was approximately 8.9% in Q1 2000 compared to 7.0% in Q1 1999. The effective tax rate was 41% in Q1 2000 versus 35% in Q1 1999.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 65% year-over-year. Organic growth was 11%, while acquisitions (net of divestitures) contributed approximately $133 million in revenue.
- Acquisitions: Completed the acquisition of Vivid Technologies, Inc. for approximately $67 million (stock merger) on January 14, 2000. This included an $8.1 million charge for in-process R&D with no alternative future use.
- Divestitures: Sold micromachined sensors and specialty semiconductor businesses for $24.3 million, resulting in a $6.7 million pre-tax gain.
- Restructuring: Recorded a $2.4 million restructuring charge due to increased employee separation costs in non-U.S. operations.
- Discontinued Operations: Q1 1999 included $6.0 million net income from the Technical Services segment, which was sold in August 1999. Q1 2000 had no discontinued operations income.
Guidance, Outlook, and Risks
- Outlook: Management expects to incur at least $30 million in cash outlays for restructuring plans throughout fiscal 2000. Most remaining actions are expected to occur in fiscal 2000.
- Capital Structure: The company refinanced its revolving credit facility in March 2000, increasing capacity from $250 million to $300 million. A shelf registration allows for up to $500 million in securities offerings.
- Accounting Changes: The company is evaluating the impact of SAB No. 101 (Revenue Recognition) and SFAS No. 133 (Derivatives). Adoption of SAB No. 101 is required effective January 3, 2000, potentially requiring restatement of Q1 2000 figures.
- Risks: Exposure to foreign exchange rate fluctuations (hedged via forward contracts) and interest rate changes. The company utilizes a Value-at-Risk model to manage these exposures.
Investor Verification Checklist
- Acquisition Accounting: Verify the final allocation of the Vivid Technologies purchase price, specifically the $8.1 million in-process R&D charge and goodwill amortization schedule.
- Restructuring Costs: Monitor the $30 million expected cash outlay for restructuring and the remaining liability of $29.6 million (1998/1999 plans) plus $13.4 million (acquisition-related plans).
- Revenue Recognition: Confirm if Q1 2000 financial statements require restatement due to the adoption of SAB No. 101 regarding customer acceptance and installation terms.
- Discontinued Operations: Track the finalization of the gain on the disposition of the Technical Services segment, which was settled in April 2000 but adjusted in Q2 2000.
- Debt Maturity: Review the maturity schedule for the $150 million secured promissory notes to PE Corp. and the $180 million commercial paper borrowings.